Business · 21/05/2018
FDA Revokes Proposed Debarment Order Against Mary C. Holloway
The FDA has revoked a proposed order to debar Mary C. Holloway for 5 years from providing services related to approved or pending drug product applications, following her request for a hearing and submission of supporting information.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →